1 study found for:    15713943 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)
Condition: Colorectal Adenoma
Interventions: Drug: MK0966; Rofecoxib / Duration of Treatment: 156 weeks;   Drug: Placebo/ Duration of Treatment: 156 weeks

Indicates status has not been verified in more than two years